Bioinspiration from Marine Scaffolds

[1]  Paola Gramatica,et al.  Principles of QSAR models validation: internal and external , 2007 .

[2]  Sorel Muresan,et al.  Developing a drug-like natural product library. , 2008, Journal of natural products.

[3]  D. Newman,et al.  Drugs and Drug Candidates from Marine Sources: An Assessment of the Current “State of Play” , 2016, Planta Medica.

[4]  Y. Pommier,et al.  Ecteinascidin 743 induces protein-linked DNA breaks in human colon carcinoma HCT116 cells and is cytotoxic independently of topoisomerase I expression. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[5]  T. Molinski,et al.  Drug development from marine natural products , 2009, Nature Reviews Drug Discovery.

[6]  Miljanich Gp,et al.  Ziconotide: neuronal calcium channel blocker for treating severe chronic pain. , 2004 .

[7]  Ronald J. Quinn,et al.  Scaffold Flatness: Reversing the Trend , 2013, Springer Science Reviews.

[8]  Hanna Geppert,et al.  Current Trends in Ligand-Based Virtual Screening: Molecular Representations, Data Mining Methods, New Application Areas, and Performance Evaluation , 2010, J. Chem. Inf. Model..

[9]  A. Schuffenhauer,et al.  Charting biologically relevant chemical space: a structural classification of natural products (SCONP). , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[10]  A. L. Risinger,et al.  Eribulin Mesylate: Mechanism of Action of a Unique Microtubule-Targeting Agent , 2015, Clinical Cancer Research.

[11]  Anang A Shelat,et al.  Scaffold composition and biological relevance of screening libraries. , 2007, Nature chemical biology.

[12]  Peter Ertl,et al.  The scaffold tree: an efficient navigation in the scaffold universe. , 2011, Methods in molecular biology.

[13]  Jun Xu,et al.  Exploring the Chemodiversity and Biological Activities of the Secondary Metabolites from the Marine Fungus Neosartorya pseudofischeri , 2014, Marine drugs.

[14]  Burkhard Haefner,et al.  Drugs from the deep: marine natural products as drug candidates. , 2003, Drug discovery today.

[15]  Q. Xiao,et al.  Absolute configurations of new limonoids from a Krishna mangrove, Xylocarpus granatum. , 2014, Fitoterapia.

[16]  Andreas Hofmann,et al.  Similar interactions of natural products with biosynthetic enzymes and therapeutic targets could explain why nature produces such a large proportion of existing drugs. , 2011, Natural product reports.

[17]  Stefan Wetzel,et al.  Interactive exploration of chemical space with Scaffold Hunter. , 2009, Nature chemical biology.

[18]  Bruno Bienfait.  Applications of High-Resolution Self-Organizing Maps to Retrosynthetic and QSAR Analysis , 1994, J. Chem. Inf. Comput. Sci..

[19]  J. Reymond.  The chemical space project. , 2015, Accounts of chemical research.

[20]  Sanjay Joshua Swamidass,et al.  Scaffold network generator: a tool for mining molecular structures , 2013, Bioinform..

[21]  A. Hopkins,et al.  Navigating chemical space for biology and medicine , 2004, Nature.

[22]  Herbert Waldmann,et al.  From protein domains to drug candidates-natural products as guiding principles in the design and synthesis of compound libraries. , 2002, Angewandte Chemie.

[23]  Andrés Francesch,et al.  Development of Yondelis (trabectedin, ET-743). A semisynthetic process solves the supply problem. , 2009, Natural product reports.

[24]  Lei Chen,et al.  Drug-likeness analysis of traditional Chinese medicines: 2. Characterization of scaffold architectures for drug-like compounds, non-drug-like compounds, and natural compounds from traditional Chinese medicines , 2013, Journal of Cheminformatics.

[25]  J. Reymond,et al.  Exploring chemical space for drug discovery using the chemical universe database. , 2012, ACS chemical neuroscience.

[26]  H. Luesch,et al.  Marine natural products: a new wave of drugs? , 2011, Future medicinal chemistry.

[27]  Tingjun Hou,et al.  Drug and Drug Candidate Building Block Analysis , 2010, J. Chem. Inf. Model..

[28]  Clemencia Pinilla,et al.  A Similarity‐based Data‐fusion Approach to the Visual Characterization and Comparison of Compound Databases , 2007, Chemical biology & drug design.

[29]  Howard S. Smith,et al.  Safety and efficacy of intrathecal ziconotide in the management of severe chronic pain , 2009, Therapeutics and clinical risk management.

[30]  Herbert Waldmann,et al.  From protein domains to drug candidates – natural products as guiding principles in , 2002 .

[31]  Stefan Wetzel,et al.  The Scaffold Tree - Visualization of the Scaffold Universe by Hierarchical Scaffold Classification , 2007, J. Chem. Inf. Model..

[32]  G. Bemis,et al.  The properties of known drugs. 1. Molecular frameworks. , 1996, Journal of medicinal chemistry.

[33]  Tudor I. Oprea,et al.  Chemography: the Art of Navigating in Chemical Space , 2000 .

[34]  Jérôme Hert,et al.  Quantifying Biogenic Bias in Screening Libraries , 2009, Nature chemical biology.

[35]  Sanjay Joshua Swamidass,et al.  Utility-Aware Screening with Clique-Oriented Prioritization , 2012, J. Chem. Inf. Model..

[36]  W. Guida,et al.  The art and practice of structure‐based drug design: A molecular modeling perspective , 1996, Medicinal research reviews.

[37]  Xiao‐Ming Li,et al.  Varioxepine A, a 3H-oxepine-containing alkaloid with a new oxa-cage from the marine algal-derived endophytic fungus Paecilomyces variotii. , 2014, Organic letters.

[38]  C. Humblet,et al.  Escape from flatland: increasing saturation as an approach to improving clinical success. , 2009, Journal of medicinal chemistry.

[39]  C. Dobson.  Chemical space and biology , 2004, Nature.

[40]  Nils M. Kriege,et al.  Visual Analysis of Biological Activity Data with Scaffold Hunter , 2013, Molecular informatics.

[41]  H. Gaspar,et al.  Marketed Marine Natural Products in the Pharmaceutical and Cosmeceutical Industries: Tips for Success , 2014, Marine drugs.

[42]  Craig J. Forsyth,et al.  Total synthesis of halichondrin B and norhalichondrin B , 1992 .

[43]  B. Petrovska,et al.  Historical review of medicinal plants’ usage , 2012, Pharmacognosy reviews.

[44]  Sarah R. Langdon,et al.  Scaffold Diversity of Exemplified Medicinal Chemistry Space , 2011, J. Chem. Inf. Model..

[45]  D. Faulkner,et al.  Marine natural products. , 2000, Natural product reports.

[46]  C. García-echeverría,et al.  Antibody-drug conjugates—a new wave of cancer drugs. , 2014, Bioorganic & medicinal chemistry letters.

[47]  Herbert Waldmann,et al.  Charting Biological and Chemical Space: PSSC and SCONP as Guiding Principles for the Development of Compound Collections Based on Natural Product Scaffolds , 2006 .

[48]  Ronald J. Quinn,et al.  Capturing Nature's Diversity , 2015, PloS one.

[49]  Lorenz C. Blum,et al.  Classification of Organic Molecules by Molecular Quantum Numbers , 2009, ChemMedChem.

[50]  A. Ganesan.  The impact of natural products upon modern drug discovery. , 2008, Current opinion in chemical biology.

[51]  Peter Ertl,et al.  Mining for Bioactive Scaffolds with Scaffold Networks: Improved Compound Set Enrichment from Primary Screening Data , 2011, J. Chem. Inf. Model..

[52]  Stefan Wetzel,et al.  Natural-product-derived fragments for fragment-based ligand discovery , 2012, Nature Chemistry.

[53]  David Rogers,et al.  Extended-Connectivity Fingerprints , 2010, J. Chem. Inf. Model..

[54]  Matthew R Trendowski.  Recent Advances in the Development of Antineoplastic Agents Derived from Natural Products , 2015, Drugs.

[55]  Tudor I. Oprea,et al.  Novel chemical space exploration via natural products. , 2009, Journal of medicinal chemistry.